#veterinary products manufacturing companies

[dredwinmedilabs]

Choosing The Best Cosmetic Products Manufacturer in India: Factors To Consider

Cosmetic Products Manufacturers in India:- The cosmetics industry is one of the most dynamic and constantly expanding industries in the world today. With a population of over 1.41 billion people, cosmetics and personal care products are in high demand. To meet this rising demand for cosmetics, young entrepreneurs are looking to enter this booming industry but lack the resources. Even well-established enterprises are willing to expand their product range. In both cases, hiring a third-party manufacturer is a viable and cost-effective approach. As a result, there are numerous Cosmetic Products Manufacturers in India, each of which claims to provide the best products at competitive prices. However, with so many options available, it can be difficult for you to choose the best one for your requirements. In this blog, we will discuss the most important factors to consider when selecting a cosmetic products manufacturer in India, so that you can make an informed decision and stay competitive.

Read more: cosmetic products manufacturer in India

#Diabetic PCD Company in India #veterinary third party manufacturers #Pharmaceutical Syrup Manufacturers in India #Cosmetic Products Manufacturers in India

[audible-smiles]

Most GP vets I know recommend glucosamine and chondroitin sulfate supplementation for dog at risk of osteoarthritis. They're both precursors to substances naturally found in cartilage, and the general claim is that supplementation reduces joint inflammation and protects cartilage from damage. Typically these are sold under the names Cosequin or Dasuquin. They're very popular with dog owners, and very commonly sold by both pet stores and vets.

I just went to a talk on osteoarthritis by an orthopedic specialist, and she claimed that these supplements were a waste of money, because they're not very bioavailable. The molecules are too large to make it through the GI system intact, and don't get to the joints where they'd be useful. So they're promising in vitro but aren't clinically useful.

So, rather than take her word for it, I looked it up. I found a 2017 literature review on the subject. Their conclusions are so frustrating that I want to quote directly from the article:

"Despite the trend towards more stringent criteria for veterinary nutraceutical products, the research community continues to conduct and publish novel, low-quality studies without consistent evaluation methods and varying products/doses...

These results are of questionable validity due to several trial shortcomings. First is the absence of therapeutic standardization. The sources of active ingredients, manufacturers of products, formulations, combinations of active ingredients, treatment doses, regimens, and durations of therapy differed significantly between trials. Second, multiple potential sources of bias were present in the trials, including the lack of a standardized follow-up timeframe, unexplained loss to follow-up, flawed study protocols, and incomplete data sets. Moreover, all of the clinical trials relied on subjective outcome measures to some extent, and the absence of standardized owner and veterinarian assessments increased the risk of bias in the reported results and diminished internal study validity.

The trials generally lacked peer review and were at risk of funding bias due to company sponsorship. Finally, there was an overall lack of generalizability of trial results. The trials were small in terms of the number of subjects used and subject baseline characteristics were not always disclosed...

Based on the available literature, the potential benefits of glucosamine and chondroitin use in osteoarthritic canines can neither be confirmed nor denied."

We are still so far behind human medicine in terms of evidence-based medicine...and human medicine is already worse than you'd hope. It's maddening. So in conclusion, I have no idea whether Cosequin/Dasuquin is helpful at all, and neither does anyone else.

#vet med #I. would like to go into veterinary research #but I have very little idea of how to do that as a tech

[canisitsnotlupus]

There is a lot of misinformation when it comes to pet food, I hope this can shed some light. - Grains are necessary (Unless diagnosed with grain allergies by a veterinarian). - Raw isn't always best. (Raw/home cooked diets need to be properly formulated by a board certified nutritionist to be balanced, more information below). - Grain free can be dangerous. - The vast majority of companies do not follow WSAVA guidelines. - Veterinarians DO NOT get kick backs from suggesting food. How are they going to get a kickback from a food you didn't even buy from them? If anything, the pet store employees are getting kick backs for suggesting foods! The “Big Five” Brands are the five brands that adhere to WSAVA guidelines (World Small Animal Veterinary Association). Which are: - Employs one or more full-time qualified nutritionist(s) and willingly discloses their credentials. - Foods are formulated by a qualified team of professionals such as nutritionists, toxicologists, food scientists etc. - Undergoes feeding trials that meet or exceed AAFCO standards, for most or all formulations. - Foods are produced and manufactured in US facilities, owned and operated by the manufacturer, or under close supervision of the manufacturer. Equipped with machinery, laboratories and staff that provide extensive on-site quality assurance. - Provides detailed description on quality control protocol. Selection criteria for partners, analysis and sample tracking of externally sourced ingredients, daily safety checks of product batches and facilities, physical inspection, key nutrient testing before final packing. - Provides exact number for any nutrient on an energy basis (grams per kcal). - Readily provides kcal content per gram and per cup. - Conducts research relevant to nutrition, products marketed, and product claims. Publishes research in peer-reviewed journals. So let’s get to it. The “Big Five” Brands are: Royal Canin - Breed specific lines that were created in conjunction with breeders and veterinarians, general health lines and targeted health lines + RX diets Eukanuba - Owned by Royal Canin, mainly their performance lines + general health lines Purina - Sport lines, general health lines, targeted health lines, most accessible and cost effective + RX diets IAMS - General health lines, cost effective, easily accessible Hills Pet - General health lines, targeted health lines + RX diets If you’d like to do some reading… Here are multiple links for kibble, raw diets, grain free vs grain inclusive, Diet Associated DCM and WSAVA. Peer reviewed resources on dog kibble: https://vetnutrition.tufts.edu/2019/03/stop-reading-your-pet-food-ingredient-list/ https://vetnutrition.tufts.edu/2016/06/why-you-shouldnt-judge-a-pet-food-by-its-ingredient-list/ https://vetnutrition.tufts.edu/2019/12/pet-food-decisions-how-do-you-pick-your-pets-food/ https://vet.osu.edu/vmc/companion/our-services/nutrition-support-service/myths-and-misconceptions-surrounding-pet-foods https://www.aaha.org/publications/newstat/articles/2017-01/myth-busters-corn-edition/ Peer reviewed resources on raw diets: https://vetnutrition.tufts.edu/2016/01/raw-diets-a-healthy-choice-or-a-raw-deal/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003575/ https://www.veterinarypracticenews.com/debating-raw-diets-january-2019/ STOLEN FROM HERE

#dcm #dog food #resource

[jcmarchi]

Open-Source Platform Cuts Costs for Running AI - Technology Org

New Post has been published on https://thedigitalinsider.com/open-source-platform-cuts-costs-for-running-ai-technology-org/

Open-Source Platform Cuts Costs for Running AI - Technology Org

Cornell researchers have released a new, open-source platform called Cascade that can run artificial intelligence (AI) models in a way that slashes expenses and energy costs while dramatically improving performance.

Artificial intelligence hardware – artistic interpretation. Image credit: Alius Noreika, created with AI Image Creator

Cascade is designed for settings like smart traffic intersections, medical diagnostics, equipment servicing using augmented reality, digital agriculture, smart power grids and automatic product inspection during manufacturing – situations where AI models must react within a fraction of a second. It is already in use by College of Veterinary Medicine researchers monitoring cows for risk of mastitis.

With the rise of AI, many companies are eager to leverage new capabilities but worried about the associated computing costs and the risks of sharing private data with AI companies or sending sensitive information into the cloud – far-off servers accessed through the internet.

Also, today’s AI models are slow, limiting their use in settings where data must be transferred back and forth or the model is controlling an automated system. 

A team led by Ken Birman, professor of computer science in the Cornell Ann S. Bowers College of Computing and Information Science, combined several innovations to address these concerns.

Birman partnered with Weijia Song, a senior research associate, to develop an edge computing system they named Cascade. Edge computing is an approach that places the computation and data storage closer to the sources of data, protecting sensitive information. Song’s “zero copy” edge computing design minimizes data movement.

The AI models don’t have to wait to fetch data when reacting to an event, which enables faster responses, the researchers said.

“Cascade enables users to put machine learning and data fusion really close to the edge of the internet, so artificially intelligent actions can occur instantly,” Birman said. “This contrasts with standard cloud computing approaches, where the frequent movement of data from machine to machine forces those same AIs to wait, resulting in long delays perceptible to the user.” 

Cascade is giving impressive results, with most programs running two to 10 times faster than cloud-based applications, and some computer vision tasks speeding up by factors of 20 or more. Larger AI models see the most benefit.

Moreover, the approach is easy to use: “Cascade often requires no changes at all to the AI software,” Birman said.

Alicia Yang, a doctoral student in the field of computer science, was one of several student researchers in the effort. She developed Navigator, a memory manager and task scheduler for AI workflows that further boosts performance.

“Navigator really pays off when a number of applications need to share expensive hardware,” Yang said. “Compared to cloud-based approaches, Navigator accomplishes the same work in less time and uses the hardware far more efficiently.”

In CVM, Parminder Basran, associate research professor of medical oncology in the Department of Clinical Sciences, and Matthias Wieland, Ph.D. ’21, assistant professor in the Department of Population Medicine and Diagnostic Sciences, are using Cascade to monitor dairy cows for signs of increased mastitis – a common infection in the mammary gland that reduces milk production.

By imaging the udders of thousands of cows during each milking session and comparing the new photos to those from past milkings, an AI model running on Cascade identifies dry skin, open lesions, rough teat ends and other changes that may signal disease. If early symptoms are detected, cows could be subjected to a medicinal rinse at the milking station to potentially head off a full-blown infection.

Thiago Garrett, a visiting researcher from the University of Oslo, used Cascade to build a prototype “smart traffic intersection.”

His solution tracks crowded settings packed with people, cars, bicycles and other objects, anticipates possible collisions and warns of risks – within milliseconds after images are captured. When he ran the same AI model on a cloud computing infrastructure, it took seconds to sense possible accidents, far too late to sound a warning.

With the new open-source release, Birman’s group hopes other researchers will explore possible uses for Cascade, making AI applications more widely accessible.

“Our goal is to see it used,” Birman said. “Our Cornell effort is supported by the government and many companies. This open-source release will allow the public to benefit from what we created.”

Source: Cornell University

You can offer your link to a page which is relevant to the topic of this post.

#A.I. & Neural Networks news #agriculture #ai #ai model #applications #approach #artificial #Artificial Intelligence #artificial intelligence (AI) #augmented reality #Bicycles #Cars #cascade #Cloud #cloud computing #cloud computing infrastructure #collisions #Companies #computation #computer #Computer Science #Computer vision #computing #dairy #data #data storage #Design #Developments #diagnostics #Disease

[moralomnivore]

If you've eaten pig in the last month, and/or intend to do so again, you owe it to the animals to see how they're being killed.

...slaughterhouses have become warier of activists, improving their physical security, tightening their access controls, and searching out hidden surveillance devices. In an earlier attempt in 2020, in fact, Deerbrook hid cameras without remote connectivity in a slaughterhouse gas chamber, but those were discovered before she could retrieve any footage.

When WIRED reached out to Smithfield Foods and shared DxE’s videos with the company, it responded in a statement that “Smithfield is committed to the safety, health, and comfort of our animals and strictly follows approved laws, regulations and best practices for humane animal stunning prior to harvest. We adhere to all humane handling and stunning regulations for livestock with the oversight of the United States Department of Agriculture Food Safety and Inspection Service.” The company pointed out that organizations like the USDA and the American Veterinary Medicine Association have recognized carbon dioxide gas chambers as complying with humane slaughter laws for years. It argued that “carbon dioxide stunning quickly renders hogs into a state of analgesia,” adding that its programs were “created in consultation with two of the world’s foremost experts in animal behavior and handling.” Gas chamber manufacturing firm Marel didn’t respond to WIRED’s request for comment.

Watch the video, read the official comment on the comfort of the animals involved, and please understand that this is what they mean when they say "humane," with legal backing. And they are actively blocking out any attempts at transparency and legally hogtying activists. Because they want their words to be the only thing on your mind when you consider buying their products, not recordings of what they actually do.

#i forced myself to watch at least the first half because if i can handle it why shouldn't you #pork #pigs #please don't @ me about your family/Good Local farm it's 'i am uncomfortable when we are not talking about me' behavior #animal death.

[alicantobiotechpvtltd]

Veterinary Medicine Manufacturer in India

veterinary medicine manufacturer in India - Alicanto Biotech is a company that specializes in producing pharmaceuticals, vaccines, and other medical products for the health and well-being of animals. Our's manufacturers adhere to strict quality standards and regulations to ensure the safety and efficacy of their products.

#health & fitness #food #nature #animals #veterinary #veterinária #home & lifestyle #dogs #aminals #healthcare #medicine #manufacturer #company #supplier

[veeremedies]

Best Veterinary Products for PCD Pharma Franchise in 2024

Best Veterinary Products for PCD Pharma Franchise in 2024 - The demand for veterinary medicine for PCD Pharma Franchise in PAN India is on the rise. People are becoming more aware of the health aspects of cattle feeding, raising and production, as well as pet healthcare. They are looking for quality, effective and affordable medicines. The veterinary PCD franchise company in India offers a wide range of pharmaceutical solutions, including pharma bolus, veterinary injectables, and cattle feed supplements, as well as nutraceuticals. To meet this growing need for veterinary medications, Vee Remedies is proud to announce its best veterinary products for PCD Pharma Franchise in 2024.

High Demand for Veterinary Products for PCD Pharma Franchise in India

The global market for veterinary medicines was estimated to be worth 46.51 billion USD in 2023 and is expected to increase from 2024 to 2030 at a compound annual growth rate (CAGR) of 8.3%. This is mainly due to the growing need for dairy products and the adoption of healthy animal eating habits. Veterinary pharmaceuticals help protect animals from harmful diseases caused by viruses and bacterial parasites. The growth and demand for veterinary pharmaceuticals are driven by the following factors - 

The increasing demand for dairy and healthy good quality meat products.

Increasing investment in animal clinical research and development for disease-free and healthy animals. 

The availability of cost-effective veterinary pharmaceuticals, in addition to the availability of veterinary clinics, has contributed to the rise in demand.

There is an ever-growing connection between people and animals that makes pet owners spend more time and money on their pets’ health and happiness. This human-animal bond motivates pet owners to look after their pets in the best possible way, no matter the cost. 

Best Veterinary Products for PCD Pharma Franchise in 2024 at Vee Remedies 

Vee Remedies supplies you with a vast selection of quality animal medicines that are safe, effective, long-lasting, and of the highest quality. They are produced and manufactured according to the established standards of veterinary pharmaceuticals, including pharma boluses, veterinary pharmaceuticals, animal liquid pharmaceuticals, cattle feed additives, nutraceuticals, etc. The units are ISO and GMP certified where the best quality assurance and quality control methods are implemented to ensure that the medicines are fully safe and effective for the treatment of the animals, cattle and livestock. With separate departments for research and Development, Quality analysis and manufacturing, we are known as top leading veterinary PCD Pharma Franchise company in India. Some of the reasons why our products are best - 

All raw materials are sourced from reliable sources. The purity of our raw material is verified using the small batch test. 

The laboratory space is dedicated to testing the drug formulations on parameters such as strength, potency, durability, purity and results. The deviations are verified and corrected before the products are made available to the end customers. 

The products are clearly labelled in an easy-to-understand format that tells you exactly what the product is made of and how it’s intended to be used on animals. 

After a series of steps, only authentic packaging materials are used for the long-term protection of animal medicinal products. The purpose of this is to ensure that the effectiveness of the medicinal product is not compromised by the packaging technique. 

Why Choose Vee Remedies for Veterinary Product PCD Pharma Franchise in India 

Vee Remedies is a highly reputed and well-experienced pharmaceutical company in India, we are providing the best-in-class highly effective Veterinary range pharmaceuticals at PAN India level. All of our products are certified and manufactured under the supervision of well-experienced healthcare professionals. We use only the best in quality raw materials, to ensure that our products are highly effective and efficient. We are providing high-demand veterinary products at a very low investment of capital. If you are looking to start your own profitable business, then Vee Remedies is the best option for you. We provide our franchise partner with such benefits as - 

WHO, GMP, and ISO-approved products

Monopoly rights

High margin profits on less investment costs

Wide range of quality products

No Sale Target

On-time delivery with leak-proof packaging 

Attractive packaging with an eye-catching appearance 

Contact details - 

Name - Vee Remedies

Address - Vee Remedies, Palam Enclave, Behind Ranjan Plaza, Sant Kirpal Nagar, Utrathiya, Zirakpur, Punjab 140604

Contact no - 98140 20377

#pcd pharma franchise #veterinary pcd pharma franchise #veterinary products for pharma franchise #pcd pharma franchise company in india #veterinary pcd pharma company #vee remedies #pharma pcd franchise

[bhushans]

Global Focus on Improved Outcomes: Global Veterinary Antibiotics Market

The global veterinary antibiotics market is projected to have a value of US$11,453.3 million in 2023. By 2033, the veterinary antibiotics market is projected to have grown at a slow 5.8% CAGR to reach US$ 20,154.0 million.

The veterinary antibiotics market is rising due to the growing animal healthcare sector and continuous innovation in the sector. Based on product type, tetracycline is expected to hold a dominant market share in the global demand for veterinary antibiotics. This is a result of its extensive use in animals raised for food.

Preview Next-Level Insights Sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-4295

Innovation and Expanding Animal Care Fuel Market Growth

The veterinary antibiotics market is poised for consistent growth, reaching an estimated value of US$20.2 billion by 2033. This growth is attributed to the continuous innovation within the animal healthcare industry and the increasing emphasis on pet health.

Tetracycline Reigns Supreme in Food Animal Production

Tetracycline antibiotics are expected to maintain their leading position within the veterinary antibiotics market. Their broad-spectrum effectiveness makes them a popular choice for treating infections in animals raised for food production.

Rising Pet Ownership and Zoonotic Disease Concerns Drive Demand

The growing number of pet owners worldwide is leading to a heightened awareness of pet health. Additionally, the increasing concern about zoonotic diseases, which can be transmitted from animals to humans, is driving the demand for effective veterinary antibiotics.

Key Takeaways:

The global veterinary antibiotics market is expected to reach US$20,154.0 million by 2033, reflecting a steady growth at a CAGR of 5.8%.

The expanding animal healthcare industry, rising pet ownership, and increasing awareness of zoonotic diseases are key drivers for market growth.

The dominance of tetracycline antibiotics used in food production animals is anticipated to continue.

How Key Players are Contributing to the Veterinary Antibiotics Market:

The veterinary antibiotics market is seeing an increase in collaboration between players. The primary reason is that collaborations provide companies access to a greater range of products and a more diverse technology set. Antibiotics generated as a result of this cooperation are of higher quality and manufactured faster.

Recent Developments Observed by FMI:

The ‘Nandi’ Portal was introduced in June 2023 to enable online approval of new veterinary drugs and vaccines in India. Nandi is an acronym for New Drug and Immunization Device Approval. As the entire form indicates, Nandi intends to make it easier for novel veterinary medications and vaccinations to receive NOCs.

For the Indian Pharmacopoeia (IP) 2022, the Indian Pharmacopoeia Commission (IPC) introduced seven new veterinary monographs and eight new chemical monographs with the intention of boosting both public and animal health in the nation. Carprofen pills, Pimobendan capsules, Selamectin, Tilmicosin, Tilmicosin injectable, and Triclabendazole are among the recently released veterinary monographs.

A partnership between the Pride Veterinary Medical Community and the United States-based animal health technology business Covetous was announced in June of 2021. Covetrus is situated in the United States. With the help of this partnership, Covetrus can offer cutting-edge veterinary medicine, which in turn empowers veterinary healthcare professionals.

Adiva GmbH and Bayer AG partnered to produce therapeutic antibodies for veterinary medicine in April 2019.

Key Players in the Global Market:

Zoetis Inc.

Merck & Co.

Bayer AG

Sanofi

Eli Lilly and Company

Ceva Sante Animale

Others

Veterinary Antibiotics Market Segmentation:

By Product Type:

Tetracyclines

Penicillins

Macrolides

Sulphonamides

Aminoglycosides

Others

By Route of Administration:

Premixes

Injections

Oral Powders

Oral Solutions

Others

By Animal Type:

Food-processing Animals

Companion Animals

By Region:

North America

Latin America

Europe

Asia Pacific

The Middle East & Africa (MEA)

#Veterinary Antibiotics Market

[industryforecastnews]

U.S. Veterinary Orthopedic Medicine Market Size, Share & Growth Analysis Report, 2030

U.S. Veterinary Orthopedic Medicine Market Growth & Trends

The U.S. veterinary orthopedic medicine market size is expected to reach USD 814.51 million by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing pet population, adoption of pet insurance, rising prevalence of diseases among animals, and advancements in veterinary medicine.

For instance, in October 2023, the FDA approved Librela (bedinvetmab injection), making it the first monoclonal antibody for treating osteoarthritis-related pain in dogs. In addition, in April 2022, American Regent Animal Health, a division of American Regent, Inc., received FDA approval to extend the shelf life of Adequan Canine and Adequan i.m. The expiration date for both products was increased from 24 months to 36 months from the date of manufacture.

Key players in the veterinary orthopedic medicine market are engaging in strategic initiatives like product launches, collaborations, and acquisitions to make their market presence more prominent, impelling market growth. In September 2022, Zoetis acquired Jurox, a private animal health company specializing in veterinary medicines for livestock and companion animals. The deal, finalized in August 2021, included Jurox's operations in Australia and regional offices in the U.S., Canada, and the UK. Such initiatives are anticipated to drive market growth.

For instance, in October 2023, Athersys, Inc. (ATHX), a cell therapy and regenerative medicine company, entered into a licensing agreement with Ardent Animal Health. With this move, Athersys, known for its work with MultiStem (invimestrocel) in critical care, entered the field of animal health. This collaboration with Ardent, a veterinary biotech firm specializing in regenerative medicine and cancer therapies for animals, highlights Athersys’ commitment to advancing veterinary care.    

Some key impacts of the pandemic and respective lockdowns on the market include dampened growth, decreased sales, supply chain disruptions, and operational challenges. However, the pandemic also propelled concerns over animal health and welfare, strengthened the pet parent and animal bond, and increased pet adoption. Moreover, the market witnessed an improved medicalization rate, pet expenditure, and adoption of pet insurance.

Increasing pet humanization and improved diagnostic rates were other positive impacts of the COVID-19 pandemic on the veterinary sector. In 2021, the market recorded increased demand and sale of veterinary medicines, including orthopedic medicines. In 2022, other macroeconomic uncertainties, such as global recession and cost inflation, adversely impacted the business. However, as the underlying market drivers remain unchanged owing to an increasing prevalence of orthopedic disorders in dogs and horses, the market is estimated to grow notably over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

U.S. Veterinary Orthopedic Medicine Market Report Highlights

Based on product, pharmaceuticals segment dominated the market, accounting for a share of 46.72% in 2023. Pharmaceutical treatments for orthopedic diseases in pets, such as Non-steroidal Anti-inflammatory Drugs (NSAIDs) and pain relievers, have been widely used and established as effective treatments for managing pain and inflammation. On the other hand, the viscosupplements segment is anticipated to grow at the fastest CAGR of 8.23% during the forecast period

Based on animal type, the market is segmented into dogs and horses. The dogs segment dominated the market, accounting for a share of 51.98% in 2023. It is also anticipated to grow at the fastest CAGR of 7.80% in the coming decade

Based on application, the osteoarthritis segment accounted for the largest share of 60.65% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 9.39% over the forecast period

Based on route of administration, the market is segmented into injectable, oral, and others (e.g., topical). The injectable segment dominated the market, accounting for a share of 60.40% in 2023. The others (e.g., topical) segment is anticipated to grow at the fastest CAGR of 8.22% in the coming decade

On the basis of end-use, veterinary clinics & hospitals segment accounted for the largest share of 53.59% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 8.68% over the forecast period

U.S. Veterinary Orthopedic Medicine Market Segmentation

Grand View Research has segmented the U.S. veterinary orthopedic medicine market based on product, animal type, application, route of administration, and end-use:

U.S. Veterinary Orthopedic Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

U.S. Veterinary Orthopedic Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

Small Breeds

Medium Breeds

Large Breeds

Horses

U.S. Veterinary Orthopedic Medicine Application Outlook (Revenue, USD Million; 2018 - 2030)

Osteoarthritis

Degenerative Joint Disease

Others

U.S. Veterinary Orthopedic Medicine Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Injectable

Intra-Muscular

Intra-Articular

Others

Oral

Others

U.S. Veterinary Orthopedic Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals & Clinics

At-home

Others

List of Key Players in the U.S. Veterinary Orthopedic Medicine Market

Zoetis Services LLC

Ardent Animal Health, LLC

Enso Discoveries

VetStem, Inc.

Contura Vet

PetVivo Holdings, Inc.

T-Cyte Therepeutics

Boehringer Ingelheim International GmbH

Arthrex, Inc.

MEDREGO LLC

Nucleus ProVets

Daiichi Sankyo Company, Limited 

Bimeda U.S.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

#U.S. Veterinary Orthopedic Medicine Market #U.S. Veterinary Orthopedic Medicine Market Size #U.S. Veterinary Orthopedic Medicine Market Trends #U.S. Veterinary Orthopedic Medicine Market Growth #U.S. Veterinary Orthopedic Medicine Market Sales

[nualterherbovet]

Third-party pharmaceutical manufacturers play a pivotal role in the pharmaceutical industry by providing manufacturing services to companies lacking production facilities or seeking to outsource production. Nualter Herbovet is the leading third-party pharmaceutical manufacturers in Uttarakhand that is specialized in producing premium herbal veterinary supplements and medications.We ensure the production of safe, effective and ethically sourced products for animal health and wellness.

#Third Party Pharma Manufacturers In Uttarakhand #Best Third Party Pharma Manufacturers In Uttarakhand #Top Third Party Pharma Manufacturers In Uttarakhand

[123567-9qaaq9]

Informative Report on “Synthetic Hormone Industry ” | Bis Research

The global synthetic hormones market refers to the collective development and production of synthetic hormones specifically designed for hormonal disorders in humans. This market includes synthetic hormones aimed at preventing and controlling disorders, including growth hormone deficiency, diabetes, contraception, male hypogonadism, menopause, and others

The Synthetic Hormone Industry size was estimated at $19.40 billion in 2023 and is expected to reach $38.08 billion by 2033, growing at a CAGR of 6.98% during the forecast period 2023-2033. 

Synthetic Hormone Industry Overview 

The synthetic hormones industry is a vital sector encompassing the production, development, and application of artificial hormones across various fields. It serves as a cornerstone for advancements in medicine, agriculture, biotechnology, and numerous other industries.

Production and Development - The industry focuses on synthesizing hormones that mimic the structure and function of naturally occurring hormones found in humans, animals, and plants. 

Agricultural and Veterinary Uses - In agriculture, synthetic hormones are employed to regulate plant growth, improve crop yield, control fruit ripening, and manage reproductive cycles in livestock. 

Market Dynamics 

Market dynamics include the factors driving and restraining the market growth along with different market opportunities. 

Market Drivers 

Increasing Prevalence of Hormonal Disorders 

Rising Awareness and Acceptance of Hormone Replacement Therapies 

Rapid Technological Advancements 

The increasing occurrence of hormonal disorders, including hypothyroidism, diabetes, and imbalances, plays a crucial role in propelling the synthetic hormones market

Market Restraints 

High Cost of Synthetic Hormones and Therapy 

Factors contributing to high costs - 

           (i) Research and Development 

           (ii) Regulatory Compliance 

           (iii) Clinical Trials and Testing 

           (iv) Intellectual Property Protection 

Stringent Regulatory processes and approval challenges of synthetic hormones 

Market Opportunities

Expanding Applications of synthetic hormones in various indications 

Precision medicine advancements, an opportunity for synthetic hormones market  

Visit our sample page click here ! 

Market Segmentation:

Segmentation 1: by Product Type

The product type segment of the global synthetic hormones market contains different types of products 

(i) Steroid Hormones 

(ii) Peptide Hormones 

(iii) Others 

Segmentation 2: by Route of Administration

The route of administration segment of the global synthetic hormones market contains different types of routes, such as:

(i) Subcutaneous 

(ii) Oral 

(iii) Intravenous

(iv) Intramuscular 

Segmentation 3: by Application

The application segment of the global synthetic hormones market contains different types of applications 

             (i)  Diabetes

             (ii)  Growth Hormone Deficiency

             (iii) Contraception

             (iv)  Male Hypogonadism

             (v)  Menopause

Segmentation 4: by End User

The end user segment of the global synthetic hormones market contains different end users, such

           (i)  Hospital Pharmacies

           (ii) Retail Pharmacies

            (iii)  Online Pharmacies

Segmentation 5 : by Region 

(i) North America 

(ii) Europe 

(iii) Latin America 

(iv) Asia- Pacific 

The primary sources involve industry experts from the synthetic hormone  industry and various stakeholders such as synthetic hormone manufacturers

Uses of Synthetic Hormone Industry

Medicine and Healthcare

Agriculture 

Research Biotechnology 

Veterinary Medicine 

Industrial Processes 

Key Players in the Synthetic Hormone Industry

Eli Lilly and Company Ferring B.V. Bayer AG Pfizer Inc. Novo Nordisk A/S Ipsen Pharma Novartis AG

Have a look at our Life Sciences and Biopharma page click here !

Key Drivers and Trends

Aging Population 

Rising Prevalence of Hormonal Disorders

Increasing Awareness and Acceptance 

Consumer Preferences 

Key Questions Answers 

Q What are the major market drivers, restraints, and opportunities within the global synthetic hormones market?

QWhat are the major trends adopted by the global synthetic hormones market?

Q What are the key strategies adopted by key players in the global synthetic hormones market?

Q  How is each product type of segment of the global synthetic hormones market expected to grow during the forecast period 2023-2033?

Q   How is each application segment of the global synthetic hormones market expected to grow during the forecast period 2023-2033?

Q  How is each end user segment of the global synthetic hormones market expected to grow during the forecast period 2023-2033?

Conclusion 

In conclusion, the synthetic hormones industry stands as a cornerstone of modern healthcare, driving innovation and advancements in medical treatment. Through the development and production of synthetic hormones, pharmaceutical companies have revolutionized the management of various health conditions, ranging from hormonal imbalances to reproductive disorders and chronic diseases. 

#synthetic hormones industry

[drugzonepharmaceuticalsinc]

The Crucial Role of Distributors in Veterinary Medicine Storage Conditions

The Crucial Role of Distributors in Veterinary Medicine Storage Conditions

When it comes to veterinary clinics, the proper storage of medications is pivotal in ensuring the effectiveness of treatments and the overall health of the animals in care. Distributors of veterinary pharmaceuticals have an integral role in this delicate system, as they are the bridge between veterinary pharma companies and the clinics that administer the medicines to our beloved animals.

Temperature-Controlled Deliveries

One of the primary responsibilities of a distributor is to maintain the integrity of medicines during transit. Since many veterinary medications require temperature-controlled environments, distributors must have proper cold chain management systems in place. Substandard transportation conditions can lead to degraded medications, which not only poses a risk to animal health but also represents a financial loss for clinics.

Education and Protocols

While veterinary pharma companies provide specifications for storage conditions, the role of the distributor is also educational. They must ensure that veterinary staff are aware of the storage parameters for each medication type. This means training on the correct usage of refrigeration units, understanding the importance of maintaining consistent temperature logs, and knowing what actions to take when equipment malfunctions occur.

Regular Inventory Checks

It's crucial for distributors to coordinate with clinics to perform regular inventory checks, ensuring that all medication is within its expiration date and has been stored under the correct conditions. These checks also provide an opportunity to remove any stock that may have compromised efficacy due to storage errors.

Technology and Monitoring

Advanced distributors employ technology to monitor and control the conditions of medications both in transit and in the clinic. Technologies such as telemetry units in delivery trucks and storage facilities allow real-time tracking of ambient conditions, and in some cases, distributors can provide clinics with smart monitoring systems that alert staff to any storage anomalies.

Conclusion

In conclusion, the role of distributors in managing medicine storage conditions is a collaborative one. It’s not just about delivering products from veterinary pharma companies to clinics; it involves an ongoing process of education, quality control, and technological investment. Only with diligent oversight and cooperation between all parties can the highest standards of veterinary care be upheld.

A distributor’s task is thus clear: they must be the vigilant custodians of veterinary medicines, from the point of manufacture to administration, ensuring efficacy and safety for animal patients everywhere.

#veterinary pharma companies #veterinary pharma

[twinknote]

I am not at all upset with u giving ur pup rawhide -- I have no dog as of yet -- but I wanna know the news so I can reassure all the pup owners in my life who are nervous!!

aaaaa sorry this is so late but I'M HERE to spread the good word

ok first of all this is Not a paid advertisement lmao but as a dog parent and professional who is very skeptical of all dog product manufacturers (and also ALWAYS believed that rawhide is bad, esp coming from a veterinary background) i will 100% be reordering this stuff for the foreseeable future

one of my fav and most trusted trainers always recommends this brand, farm hounds, bc ppl are always asking what chews she buys for her dogs, one of whom is a chewing Machine. i got a coupon from her and (skeptically) ordered their rawhide rolls BECAUSE:

the vast majority of standard rawhide products only use the inner layer of hide; the top outermost layer is used for tanning bc it's more durable and leather sells for more $ than dog chews. the hide from this company uses the Entire hide sourced from small farms

standard rawhide is also chemically treated (which is why it's generally that light white-ish color) to speed up the production process to make more $ instead of allowing them to dry naturally, which this company does

so i have two big dogs at home who love to chew. so i ordered these and started giving them 20-30 min daily chew sessions (1. edible chews like this should always be supervised 2. that's enough time for all the satisfying chewing endorphins to be released in their little brains and for them to scrape off the plaque from their teef, and 3. i wanted the hides to last longer than 2 days lmao)

and i am genuinely So impressed by how long they lasted and how durable they were. the other dog nola (60lb) actually still has like half of hers left after almost 2 weeks, and the only reason echo (90lb) finished hers is bc ppl have been working on the house and she was rly stressed so i just let her chew while someone was working in her line of sight for a while

ok ty for coming to my ted talk on rawhide, moral of the story: don't buy regular rawhide but some of it is actually good and dogs need to chew on non-plastic stuff. also here is a link to their website, they also have other chews and treats that are ethically sourced and produced! (i stg this is not a fucking advertisement shkjshhsd i'm just glad to have found them bc most manufacturers Suck)

#my rawhide ted talk etc. #ask

[govindtbrc]

Healing Hands: Insights into the Veterinary Equipment and Supplies Market

Veterinary medicine plays a vital role in ensuring the health and well-being of animals, from beloved pets to farm livestock. Behind every successful veterinary practice lies a suite of specialized equipment and supplies designed to diagnose, treat, and care for animals. This article explores the significance of veterinary equipment and supplies, their key roles, and the evolving landscape of the veterinary equipment market.

Veterinary equipment and supplies encompass a wide range of tools, instruments, devices, and consumables used by veterinarians, veterinary technicians, and animal healthcare professionals in clinical practice, research, and laboratory settings. These essential resources enable veterinary professionals to perform diagnostic tests, surgical procedures, dental treatments, imaging studies, and preventive care measures to keep animals healthy and thriving.

One of the key roles of veterinary equipment and supplies is to support diagnostic and imaging capabilities, allowing veterinarians to accurately assess the health status of animals and formulate appropriate treatment plans. Equipment such as diagnostic analyzers, ultrasound machines, X-ray systems, and MRI scanners enable veterinarians to identify medical conditions, injuries, and diseases in animals with precision and accuracy.

Request the sample copy of report @ https://www.globalinsightservices.com/request-sample/GIS24951

Moreover, veterinary equipment and supplies are essential for surgical interventions and medical procedures, providing veterinarians with the tools and instruments needed to perform surgeries, administer anesthesia, and provide post-operative care. Surgical instruments, anesthesia machines, monitoring devices, and sterile supplies are critical components of any veterinary surgical suite, ensuring the safety and comfort of animals undergoing procedures.

Furthermore, veterinary equipment and supplies play a crucial role in dental care, ophthalmology, and dermatology, allowing veterinarians to address oral health issues, eye conditions, and skin disorders in animals. Dental instruments, dental radiography equipment, ophthalmic instruments, and dermatological treatments are essential for maintaining the oral hygiene, visual acuity, and skin health of animals under veterinary care.

The veterinary equipment and supplies market serves a diverse range of stakeholders, including veterinary clinics, animal hospitals, research laboratories, universities, and veterinary pharmaceutical companies, where products and services related to animal health and care are in demand. With the increasing prevalence of pets, livestock, and companion animals, the demand for veterinary equipment and supplies is expected to rise in parallel.

Moreover, the veterinary equipment and supplies market is driven by factors such as technological advancements, innovation in product design, and the growing emphasis on animal welfare and preventive healthcare. Manufacturers are investing in research and development to develop new technologies, devices, and treatments to address emerging needs and challenges in veterinary medicine.

In conclusion, veterinary equipment and supplies are indispensable tools for delivering high-quality care and treatment to animals in veterinary practice. By providing veterinarians with the resources they need to diagnose, treat, and care for animals, veterinary equipment and supplies play a vital role in promoting animal health, welfare, and well-being. As the veterinary profession continues to evolve and expand, the veterinary equipment and supplies market will remain a dynamic and essential component of animal healthcare worldwide.

[benstiller77]

Rising Demand For Advanced Ophthalmic Imaging Systems To Fuel Growth Of The Global Optical Instrument And Lens Market

 The global optical instrument and lens market involves a wide range of precision instruments and specialty lenses that are used in applications ranging from microscopy to ophthalmology. Optical instruments help in examining, measuring and inspecting minute details and structures that cannot be perceived through naked eyes. Meanwhile, optical lenses have become integral components across various consumer electronic devices as well as industrial and medical equipment. Technological advancements have enabled the development of novel optical instruments and high-precision lenses that offer improved resolution, accuracy and functionality. The growing need for early disease diagnosis and treatment is propelling demand for advanced ophthalmic imaging systems among eye care professionals globally.

The Global Optical Instrument And Lens Market Size Is Estimated To Be Valued At US$ 29.8 Bn In 2024 And Is Expected To Exhibit A CAGR Of 4.7% Over The Forecast Period 2024-2031. Key Takeaways Key players operating in the global optical instrument and lens market are Carl Zeiss Ag, Hoya Corporation, Canon Inc., Nidek Co., Ltd., Topcon Corporation, Intelligent Retinal Imaging Systems, Inc., Kowa Company Ltd., Optomed, Vision Equipment Inc., Clarity Medical Systems, Inc., Medimaging Integrated Solution Inc., S4OPTIK LLC., Shenzhen Thondar Technology Co., Ltd., CenterVue SpA, Alton Vision LLC, LENSTECH OPTICALS, Alcon Inc. These players are focusing on developing advanced optical instruments and lenses through investments in R&D. The global market is driven by the rising geriatric population and increasing prevalence of ocular diseases. According to WHO, at least 2.2 billion people have vision impairment or blindness globally. This is spurring demand for ophthalmic diagnostic equipment and lenses. Technological advancements are allowing manufacturers to develop more compact, high-resolution and precision optical instruments integrated with advanced imaging and analytical capabilities. This is supporting applications in diverse fields including life sciences, industrial inspection and healthcare. Market Trends Some of the key trends observed in the global optical instrument and lens market include rising adoption of hybrid imaging systems and multifunctional optical instruments. Manufacturers are integrating capabilities of different imaging modalities into single platforms to improve workflow and diagnostic capabilities. Another trend gaining traction is the emergence of 3D printed ophthalmic lenses with customized prescriptions and designs. 3D printing technology enables mass-personalization of lenses as per the specific vision requirements of individuals. Market Opportunities The market players have opportunity to tap into the growing demand for tele-ophthalmology and remote patient monitoring solutions. There is a need for portable diagnostic devices integrated with telecommunication capabilities. Another opportunity lies in developing nations in Asia Pacific and Latin America driven by improving healthcare infrastructure and increasing healthcare spending. Expansion of product offerings catering to veterinary and industrial applications also presents lucrative growth prospects.

Get more insights on this topic: https://www.pressreleasebulletin.com/global-optical-instrument-and-lens-market-growth-size-and-demand/

#Global Optical Instrument and Lens Market Trend #Global Optical Instrument and Lens Market Growth #Global Optical Instrument and Lens Market Size #Global Optical Instrument and Lens Market Analysis

[zenfoldst]

Products,Zenfold Sustainable Technologies,ZST.

We manufacture complex chemical molecules that are used by pharmaceutical companies, nutraceutical companies, cosmetic companies, and veterinary medicine.